Methoxy polyethylene glycol-epoetin beta (Mircera) is a medication used to treat anemia (low red blood cell count) caused by chronic kidney disease. It is a form of erythropoietin, a naturally occurring hormone in the body that helps to produce red blood cells. Mircera works by stimulating the production of red blood cells in the bone marrow. It is given by injection and can be used as an alternative to other erythropoiesis-stimulating agents (ESAs). Common side effects include dizziness, headache, nausea, and an increase in blood pressure.
Methoxy polyethylene glycol-epoetin beta, also known by the brand name Mircera, is a medication used to treat anemia caused by chronic kidney disease. It belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs) which stimulate the production of red blood cells in the bone marrow.
Here's a summary of how Methoxy polyethylene glycol-epoetin beta works:
- It is a modified version of erythropoietin, a hormone naturally produced by the kidneys that helps the body produce red blood cells.
- In people with chronic kidney disease, the kidneys are unable to produce enough erythropoietin, leading to a deficiency and consequently, anemia.
- Methoxy polyethylene glycol-epoetin beta works by mimicking the effects of natural erythropoietin and stimulating the bone marrow to produce more red blood cells.
Important points to remember:
- This medication is administered through injection, either subcutaneously (under the skin) or intravenously (into a vein).
- It is typically administered once every two weeks, however, the dosage and frequency may vary depending on the individual's needs and response to the medication.
- Methoxy polyethylene glycol-epoetin beta is a prescription medication and should only be taken under the supervision of a qualified healthcare professional.